Clinical Trial Update: A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis [Phase 3]

View source ↗

Summary

Infliximab (Remicade) was studied in a Phase 3 trial for active ulcerative colitis, focusing on safety and efficacy. The study status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Centocor, Inc. | Conditions: Ulcerative Colitis | Phase 3 | Status: COMPLETED